Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2014; 20(46): 17532-17540
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17532
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17532
Figure 3 Dot plot showing plasma cathepsin L levels in pancreatic cancer patients who underwent resection (Resectable; n = 25); who were found to be resectable based on imaging but were irresectable on further investigation (Per-op.
Irresectable; n = 15); who were un-resectable due to locally advanced disease (Un-resectable; n = 37); or who had metastasis at presentation (Metastasis; n = 53).
- Citation: Singh N, Das P, Gupta S, Sachdev V, Srivasatava S, Datta Gupta S, Pandey RM, Sahni P, Chauhan SS, Saraya A. Plasma cathepsin L: A prognostic marker for pancreatic cancer. World J Gastroenterol 2014; 20(46): 17532-17540
- URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17532.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17532